Assembly Biosciences, Inc. is a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral biotherapeutics for disorders associated with the microbiome.


See all news


June 26, 2017
June Investor Presentation
June 07, 2017
Jefferies 2017 Global Healthcare Conference